Clarivate in partnership with Abiquifi Announces Annual Summit LATAM Agenda
Clarivate and Abiquifi have announced the agenda for the 2nd annual Summit LATAM, scheduled for October 7, 2024, in Milan. The event, preceding CPHI Milan, will focus on AI, data, strategic partnerships, and innovation opportunities in the Latin American pharmaceutical market, valued at $98 billion with projected growth of 10.1%.
Key sessions will cover topics such as driving growth with data and AI, competitive partnerships, regulatory guidelines, and local API production. The summit aims to address challenges and uncover opportunities in the region's evolving pharmaceutical landscape. Industry leaders from Clarivate, Abiquifi, Knight Therapeutics, EMS, Gene Pharm, Libbs Farmacêutica, ANVISA, Nortec, Emcure Mexico, and Globe Química will share insights and perspectives.
Clarivate e Abiquifi hanno annunciato l'agenda per il 2° Summit LATAM, in programma il 7 ottobre 2024 a Milano. L'evento, che precederà il CPHI Milano, si concentrerà su AI, dati, partnership strategiche e opportunità di innovazione nel mercato farmaceutico latinoamericano, valutato 98 miliardi di dollari con una crescita prevista del 10,1%.
Le sessioni principali tratteranno argomenti come stimolare la crescita con dati e AI, partnership competitive, linee guida normative e produzione locale di API. Il summit ha l'obiettivo di affrontare le sfide e scoprire opportunità nel panorama farmaceutico in evoluzione della regione. Leader del settore di Clarivate, Abiquifi, Knight Therapeutics, EMS, Gene Pharm, Libbs Farmacêutica, ANVISA, Nortec, Emcure México e Globe Química condivideranno intuizioni e prospettive.
Clarivate y Abiquifi han anunciado la agenda para la 2ª Cumbre LATAM, programada para el 7 de octubre de 2024 en Milán. El evento, que precederá al CPHI Milán, se centrará en IA, datos, asociaciones estratégicas y oportunidades de innovación en el mercado farmacéutico latinoamericano, valorado en 98 mil millones de dólares con un crecimiento proyectado del 10.1%.
Las sesiones clave abordarán temas como impulsar el crecimiento con datos e IA, asociaciones competitivas, directrices regulatorias y producción local de API. La cumbre tiene como objetivo enfrentar desafíos y descubrir oportunidades en el panorama farmacéutico en evolución de la región. Líderes de la industria de Clarivate, Abiquifi, Knight Therapeutics, EMS, Gene Pharm, Libbs Farmacêutica, ANVISA, Nortec, Emcure México y Globe Química compartirán ideas y perspectivas.
Clarivate와 Abiquifi가 2024년 10월 7일 밀라노에서 열릴 제2회 LATAM 서밋의 일정을 발표했습니다. CPHI 밀라노에 앞서 열리는 이번 행사에서는 AI, 데이터, 전략적 파트너십 및 라틴 아메리카 제약 시장의 혁신 기회에 초점을 맞출 예정이며, 이 시장은 980억 달러로 평가되며 10.1%의 성장률이 예상됩니다.
주요 세션에서는 데이터 및 AI를 통해 성장을 촉진하는 방법, 경쟁 파트너십, 규제 가이드라인, 현지 API 생산 등의 주제가 다뤄질 것입니다. 이번 서밋은 지역의 변화하는 제약 환경에서 도전 과제를 해결하고 기회를 발굴하는 것을 목표로 하고 있습니다. Clarivate, Abiquifi, Knight Therapeutics, EMS, Gene Pharm, Libbs Farmacêutica, ANVISA, Nortec, Emcure 멕시코, Globe Química의 산업 리더들이 통찰력과 관점을 공유할 것입니다.
Clarivate et Abiquifi ont annoncé l'agenda du 2e Sommet LATAM, prévu pour le 7 octobre 2024 à Milan. L'événement, qui précédera le CPHI Milan, se concentrera sur IA, données, partenariats stratégiques et opportunités d'innovation dans le marché pharmaceutique latino-américain, évalué à 98 milliards de dollars avec une croissance projetée de 10,1 %.
Les sessions clés aborderont des sujets tels que la stimulation de la croissance grâce aux données et à l'IA, les partenariats concurrentiels, les lignes directrices réglementaires et la production locale d'API. Le sommet vise à relever les défis et à découvrir des opportunités dans le paysage pharmaceutique en évolution de la région. Des leaders de l'industrie de Clarivate, Abiquifi, Knight Therapeutics, EMS, Gene Pharm, Libbs Farmacêutica, ANVISA, Nortec, Emcure Mexique et Globe Química partageront leurs idées et perspectives.
Clarivate und Abiquifi haben die Agenda für den 2. jährlichen LATAM Gipfel angekündigt, der am 7. Oktober 2024 in Mailand stattfindet. Die Veranstaltung, die dem CPHI Mailand vorausgeht, wird sich auf KI, Daten, strategische Partnerschaften und Innovationsmöglichkeiten im lateinamerikanischen Pharmamarkt konzentrieren, der mit 98 Milliarden US-Dollar bewertet wird und ein prognostiziertes Wachstum von 10,1% aufweist.
Wichtige Sitzungen werden Themen wie Wachstumsförderung durch Daten und KI, wettbewerbsfähige Partnerschaften, regulatorische Richtlinien und lokale API-Produktion behandeln. Der Gipfel hat zum Ziel, Herausforderungen anzugehen und Chancen im sich entwickelnden pharmazeutischen Umfeld der Region zu erkennen. Branchenführer von Clarivate, Abiquifi, Knight Therapeutics, EMS, Gene Pharm, Libbs Farmacêutica, ANVISA, Nortec, Emcure Mexiko und Globe Química werden Erkenntnisse und Perspektiven teilen.
- Summit LATAM 2024 focuses on the fast-growing Latin American pharmaceutical market, valued at $98 billion with 10.1% projected growth
- Event brings together industry leaders to address challenges and uncover innovation opportunities in the region
- Agenda covers important topics such as AI, data, strategic partnerships, and local API production
- None.
Top industry leaders to explore AI, data, strategic partnerships, and innovation opportunities in
In the wake of the pandemic, the global pharmaceutical industry faced a slowdown in growth, prompting companies to swiftly identify new opportunities and areas of innovation. As the Latin American market is valued at
Henry Levy, President, Life Sciences and Healthcare, Clarivate, said: "At Clarivate, we have been committed to driving innovation and delivering strategic solutions in
Norberto Prestes, President, Abiquifi, said: "There can be no serious and efficient planning if we don't have quality data. Abiquifi has innovation as a priority part of its strategy and to this end we are expanding our partnership with Clarivate so that we can carry out a quality LATAM mobilization in order to expand the production and development of innovative IFAS in the bloc. The meetings we hold in each country are guided by the data provided by Clarivate. The high-quality information brings the LATAM reality to the center of discussions and helps us define priorities, understand where there are opportunities to act in the medium term and what we should invest in long-term research in the region."
Cristian Madoery, Director Sales Latam, Life Sciences and Healthcare, Clarivate, said: "Summit LATAM Milan offers a valuable opportunity to connect with key leaders in the Latin American pharmaceutical sector. Clarivate has been actively fostering an ecosystem in
This year's agenda features insights and perspectives from industry leaders and analysts, with sessions focused on innovative partnerships, artificial intelligence, regulatory guidelines and API production. Noteworthy sessions include:
- From information to innovation: Driving growth in
Latin America with data and artificial intelligence, presentation by Cristian Madoery, Director Sales Latam, Life Sciences & Healthcare, Clarivate and Leticia Terra, Solutions Consultant, Life Sciences and Healthcare, Clarivate - Interactions and partnerships in
Latin America : Strategy or survival? Identifying and executing competitive partnership, panel discussion by Stephani Saverio, VP Business Development, Knight Therapeutics, Juliana Megid, Institutional Relations Director, EMS, Federico Rivera, Business Development, Gene Pharm and Anna Paula Guembes, New Business Director, Libbs Farmacêutica - Implementation of regulatory guidelines attractive to the market and aimed at optimizing access to the population, by Marcus Aurelio Miranda de Araujo, General Manager of GGFIS, ANVISA
- Local API production: What's missing in
Latin America ? With strategies based on the search for sustainable raw materials, panel discussion by Norberto Prestes, Executive President, Abiquifi, Marcelo Mansur, CEO, Nortec and Javier Mestre, General Manager, Emcure Mexico and José Ézio Nogueira, CEO, Globe Química
Notes to editors
Summit LATAM takes place on Monday, October 7, 2024, at the Hotel NH Collection,
Meet the Clarivate Latam team at Pharma Connection, hosted by Abiquifi on October 7, 2024 at Hotel NH Collection,
Following the summit, join the Clarivate team of life sciences and healthcare experts at CPHI Milan 2024 from Oct 8-10 at booth 14F84 or at the Brazilian Delegation. Learn how to transform complex markets, API, and regulatory data into actionable insights. Meet with the Clarivate team, here.
Connect with Clarivate Life Sciences and Healthcare. Join the conversation and mention Clarivate and Summit LATAM on X and LinkedIn. #SummitLATAM #PatientCare #Pharma #Clarivate #ThinkForward
About Abiquifi
Founded in 1983, the Brazilian Association of the Pharmaceutical Ingredients Industry (Abiquifi) is a non-profit organization that brings together the main companies in the pharma-chemical sector in
About Clarivate
Clarivate™ is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com
Media Contact:
Luna Ivkovic
External Communications, Life Sciences & Healthcare
newsroom@clarivate.com
1 Source: PharmaBoardroom. (2022). Infigures:
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-in-partnership-with-abiquifi-announces-annual-summit-latam-agenda-302267011.html
SOURCE Clarivate Plc
FAQ
When and where will Clarivate's Summit LATAM 2024 take place?
What is the projected growth rate for the Latin American pharmaceutical market according to Clarivate (CLVT)?
What are the main topics to be discussed at Clarivate's Summit LATAM 2024?
Who are some of the key industry leaders participating in Clarivate's Summit LATAM 2024?
